Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.
Milestones
1999 | Preparation |
2001 | Officially established |
2008 | It was wholly-owned by Chongqing Zhifei Biological Products Co.,Ltd |
2010 | Chongqing Zhifei Biological Products Co., Ltd. was listed on GEM of Shenzhen Stock Exchange |
2011 | Construction of biological products production and R & D center projects. |
2013 | Changed its name to Anhui Zhifei Longcom Biopharmaceutical Co., LTD. Granted as a pharmaceutical GMP practice training base |
2014 | Awarded with the high-tech enterprise certification for the first time Granted with the title of Anhui Provincial Engineering research Center for Novel Human Vaccine |
2016 | Granted as an Innovation Base of TB translational Medicine of China National Defense Tuberculosis Association |
2018 | Its biopharmaceutical Industrial Park (Area A) construction was officially started. |
2020 | Recombinant Mycobacterium tuberculosis fusion Protein (EC) (trade name: EC-Test ®) was approved for drug registration. |